INFLUENCE OF A STATIN THERAPY ON THE ELECTRICAL PROPERTIES OF ATRIAL AND VENTRICULAR MYOCARDIUM IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH A SUBCLINICAL HYPOTHYROIDISM (19-24)

Список литературы: 1. Radulescu D, Stoicescu L, Buzdugan E, Donca V. Patterns of left ventricular remodeling among patients with essential and secondary hypertension. Revista médica de Chile. 2013;141(12):1520-1527. doi:10.4067/s0034-98872013001200004 2. Sultana R, Sultana N, Rashid A, Rasheed SZ, Ahmed M, Ishaq M, Samad A. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension. J Ayub Med Coll Abbottabad. 2010;22(4):155-8. 3. Shenasa M, Shenasa H, El-Sherif N. Left Ventricular Hypertrophy and Arrhythmogenesis. Cardiac Electrophysiology Clinics. 2015;7(2):207-220. doi:10.1016/j.ccep.2015.03.017 4. Kahan T, Bergfeldt L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. 2005;91(2):250-256. doi:10.1136/hrt.2004.042473 5. Yiu K-H, Tse H-F. Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications. Journal of Human Hypertension. 2008;22(6):380-388. doi:10.1038/jhh.2008.10 6. Santangeli P, Infusino F, Sgueglia GA, Sestito A, Lanza GA. Ventricular late potentials: a critical overview and current applications. Journal of Electrocardiology. 2008;41(4):318-324. doi:10.1016/j.jelectrocard.2008.03.001 7. Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study. American Heart Journal. 2002;143(6):991-1001. doi:10.1067/mhj.2002.122875 8. Kannel W, Wolf P, Benjamin E, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available. The American Journal of Cardiology. 1998;82(7):2N-9N. doi:10.1016/s0002-9149(98)00583-9 9. Verdecchia P, Reboldi G, Gattobigio R, et al. Atrial Fibrillation in Hypertension. Hypertension. 2003;41(2):218-223. doi:10.1161/01.hyp.0000052830.02773.e4 10. Madu EC, Baugh DS, David Gbadebo T, Dhala A, Cardoso S. Effect of ethnicity and hypertension on atrial conduction: Evaluation with high-resolution p-wave signal averaging. Clinical Cardiology. 2001;24(9):597-602. doi:10.1002/clc.4960240906 11. Baguet J-P, Erdine S, Mallion J-M. Hypertension and arrhythmia. European Society of Hypertension Scientific Newsletter: Update on Hypertension Management. 2005;6:24. https://www.eshonline.org/eshcontent/uploads/2014/12/24_Newsletter- Hypertension-and-Arrhythmia.pdf 12. Mozoş I, Şerban C, Mihăescu R. Late Ventricular Potentials in Cardiac and Extracardiac Diseases. Cardiac Arrhythmias - New Considerations. February 2012. doi:10.5772/25415 13. Barbosa PRB, de Souza Bomfim A, Barbosa EC, et al. Spectral turbulence analysis of the signalaveraged electrocardiogram of the atrial activation as predictor of recurrence of idiopathic and persistent atrial fibrillation. International Journal of Cardiology. 2006;107(3):307-316. doi:10.1016/j.ijcard.2005.03.073 14. Galinier M, Balanescu S, Fourcade J, et al. Prognostic value of arrhythmogenic markers in systemic hypertension. European Heart Journal. 1997;18(9):1484-1491. doi:10.1093/oxfordjournals.eurheartj.a015476 15. Benchimol-Barbosa PR, Barbosa EC, Bomfim AS, Ginefra P, Nadal J. Clinical assessment of the effect of digital filtering on the detection of ventricular late potentials. Brazilian Journal of Medical and Biological Research. 2002;35(11):1285-1292. doi:10.1590/s0100-879x2002001100005 16. Ramos JA, dos Santos PJL. Parametric Modeling in Estimating Abnormal Intra-QRS Potentials in Signal-Averaged Electrocardiograms: A Subspace Identification Approach. IFAC Proceedings Volumes. 2012;45(16):565-570. doi:10.3182/20120711-3-be-2027.00402 17. Abdelghani SA, Rosenthal TM, Morin DP. Surface Electrocardiogram Predictors of Sudden Cardiac Arrest. Ochsner J. 2016;16(3):280–289. 18. Сыволап В.В. Новиков Е.В. Электрические свойства миокарда у больных артериальной гипертензией, сочетанной с субклиническим гіпотиреозом // Запорожский медицинский журнал. 2019. Т. 21, № 5(116). С. 582–589 DOI: 10.14739/2310-1210. 2019.5.179405[Syvolap, V. V., Novikov, Ye.V. (2019). Electrical properties of the myocardium in patients with arterial hypertension combined with subclinical hypothyroidism. Zaporozhye medical journal, 5(116), 582–589. DOI: 10.14739/2310-1210. 2019.5.179405 ] 19. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010t;12(10):1360-420. 20. Savelieva I., Camm A.J. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation. Nat Clin Pract Cardiovasc Med 2008; 5: 30-41. 21. Savelieva I., Kourliouros A., Camm J. Primary and secondary prevention of atrial fibrillation with statin and polyunsaturated fatty acids: review of evidence and clinical relevance. Naunyn Schmiedebergs Arch Pharmacol 2010; 381: 1-13. 22. Santangeli P., Ferrante G., Pelargonio G., et al. Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review. Europace 2010; 12: 649-54. 23. Patti G., Chello M., Candura D., et al. Randomized trial of atorvastatin for reduction оf postoperative atrial fibrillation in patients undergoing cardiac surgery: results of thе ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114:1455-61. 24. Liakopoulos O.J., Choi Y.H., Kuhn E.W., et al. Statins for prevention of atrial fibrillation after cardiac surgery:a systematic literature review. J Thorac Cardiovasc Surg 2009; 138: 678-86e1. 25. Almroth H., Hoglund N., Boman K., et al. Atorvastatin and persistent atrial fibrillation following cardioversion:a randomized placebo-controlled multicentre study. Eur Heart J 2009; 30: 827-33. 26. Fauchier L., Pierre B., de Labriolle A., et al. Antiarrhythmic effect of statin therapy and atrial fibrillation:a meta-analysis of randomized controlled trials. JACC 2008; 51: 828-35. 27. Liu T., Li L., Korantzopoulos P., et al. Statin use and development of atrial fibrillation: a systematic reviewand meta-analysis of randomized clinical trials and observational studies. Int J Cardiol 2008; 126:160170. 28. Yang Q, Qi X1, Li Y.The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 2014;14:99. 29. Подзолков В.И., Тарзиманова А.И., Гатаулин Р.Г. Статины во вторичной профилактике фибрилляции предсердий.//Рациональная фармакотерапия в кардиологии2016;12(5). С. 517521. DOI: 10.20996/1819-6446-2016-12-5-517-521. [ Podzolkov V.I., Tarzimanova A.I., Gataulina R. Statiny vo vtorichnoy profilaktike fibrillyatsii predserdiy // Ratsional'naya farmakoterapiya v kardiologii 2016; 12 (5). S. 517-521. DOI: 10.20996 / 1819-6446-2016-12- 5-517-521.] 30. Е. С. Козлова , Немчук Ф.А., Лопатин Ю.М. Аторвастатин и нарушения ритма сердца. Взгляд на механизм действия.//Вестник Волгоградского государственного медицинского университета. 2010. 1(33). С. 86-90 [E. S. Kozlova, NemchukF.A., LopatynYU.M. Atorvastatin i narusheniya ritma serdtsa.. Vzglyad na mekhanizm deystviya.// Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta. 2010. 1 (33). S. 86-90] 31. Артеріальна гіпертензія. Оновлена та адаптована клінічна настанова, заснована на доказах (2012 рік): практичні рекомендації [Текст] / Робоча група з артеріальної гіпертензії Укр. Асоц. Кардіологів // Артериальная гипертензия. – 2012. - №1[Arterialʹnahipertenziya. Onovlena ta adaptovana klinichna nastanova, zasnovana na dokazah (2012 rik): Praktychni rekomendatsiyi [Tekst] / Robocha hrupa z arterialʹnoyi hipertenziyi Ukr. Asots. Kardiolohiv // Arterialʹna hipertenziya. - 2012. - №1] 32. Pearce, Brabant, G., Duntas, L., Monzani, F., Peeters, R., Razvi, S., &Wemeau, J. (2013).ETAGuideline: Managemen to Subclinical Hypothyroidism. EurThyroidJ, 2, 215-228.